Scholarlink

<p>Women with a genetic predisposition for breast and gynecologic cancer have concerns that hormonal interventions could increase their genetic cancer risk. As a result, they are often excluded from endocrine interventions for fertility treatment, contraception, hormone replacement after risk-reducing salpingo-oophorectomy (RRSO), or from treatment of peri- and postmenopausal symptoms. The following statements and recommendations were formulated by the Hormone Working Group of the German Consortium for Hereditary Breast and Ovarian Cancer and are meant to support physicians in counseling affected women.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Risiko endokriner Interventionen bei Trägerinnen einer genetischen Disposition für Brustkrebs und gynäkologische Krebserkrankungen

  • 期刊论文

  • 发表日期：

    2026年3月26日

查看全文
  • Susanne Schüler-Toprak,
  • Karin Kast,
  • Olaf Ortmann,
  • T. Fehm,
  • A. Hahne,
  • D. Huber,
  • K. Kast,
  • E. Kühnle,
  • K. Mohr,
  • O. Ortmann,
  • K. Rhiem,
  • S. Schüler-Toprak,
  • S. Seitz,
  • D. Speiser

摘要

Women with a genetic predisposition for breast and gynecologic cancer have concerns that hormonal interventions could increase their genetic cancer risk. As a result, they are often excluded from endocrine interventions for fertility treatment, contraception, hormone replacement after risk-reducing salpingo-oophorectomy (RRSO), or from treatment of peri- and postmenopausal symptoms. The following statements and recommendations were formulated by the Hormone Working Group of the German Consortium for Hereditary Breast and Ovarian Cancer and are meant to support physicians in counseling affected women.